LivaNova has announced that the U.S. Food & Drug Administration (FDA) has granted premarket approval (PMA) for the aura6000 System for the treatment of adult patients with moderate to severe obstructi ...

HONOLULU -- Oral appliance therapy may be a promising alternative to continuous positive airway pressure (CPAP) in elderly patients with obstructive sleep apnea (OSA), a pilot study suggested. Among ...

LivaNova LIVN recently received premarket approval from the FDA for its aura6000 system to treat adults with moderate to ...

Device will not carry concentric collapse contraindication or warning language ...

LivaNova (Nasdaq:LIVN) announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system ...

Please provide your email address to receive an email when new articles are posted on . Researchers found heightened odds for mortality among veterans with no sleep apnea vs. with mild to moderate ...

This new study investigated a potential link found that apnea hypopnea index during the rapid eye movement (REM) sleep stage was associated with hypertension in patients with obstructive sleep apnea.

Available evidence "mostly does not support" a link between continuous positive airway pressure therapy and long-term, clinically important outcomes for obstructive sleep apnea, according to a U.S.

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

Please provide your email address to receive an email when new articles are posted on . Several clinical and CPAP-related variables were linked to a greater risk for high residual apnea-hypopnea index ...

Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam ...